These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11291079)

  • 1. Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma.
    Van Gele M; Leonard JH; Van Roy N; Cook AL; De Paepe A; Speleman F
    Int J Cancer; 2001 May; 92(3):409-13. PubMed ID: 11291079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
    Kurose K; Zhou XP; Araki T; Eng C
    Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
    Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
    Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation.
    Marsh DJ; Dahia PL; Coulon V; Zheng Z; Dorion-Bonnet F; Call KM; Little R; Lin AY; Eeles RA; Goldstein AM; Hodgson SV; Richardson AL; Robinson BG; Weber HC; Longy M; Eng C
    Genes Chromosomes Cancer; 1998 Jan; 21(1):61-9. PubMed ID: 9443042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
    Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
    Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines.
    Pollock PM; Walker GJ; Glendening JM; Que Noy T; Bloch NC; Fountain JW; Hayward NK
    Melanoma Res; 2002 Dec; 12(6):565-75. PubMed ID: 12459646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas.
    Reifenberger J; Wolter M; Boström J; Büschges R; Schulte KW; Megahed M; Ruzicka T; Reifenberger G
    Virchows Arch; 2000 May; 436(5):487-93. PubMed ID: 10881743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic loss at 10q23.3 but lack of mutation of PTEN/MMAC1 in chromophobe renal cell carcinoma.
    Sükösd F; Digon B; Fischer J; Pietsch T; Kovacs G
    Cancer Genet Cytogenet; 2001 Jul; 128(2):161-3. PubMed ID: 11463457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.
    Gimm O; Chi H; Dahia PL; Perren A; Hinze R; Komminoth P; Dralle H; Reynolds PR; Eng C
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1801-5. PubMed ID: 11297621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma.
    Alimov A; Li C; Gizatullin R; Fredriksson V; Sundelin B; Klein G; Zabarovsky E; Bergerheim U
    Anticancer Res; 1999; 19(5B):3841-6. PubMed ID: 10628321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of PTEN mutations in metastatic melanoma specimens.
    Celebi JT; Shendrik I; Silvers DN; Peacocke M
    J Med Genet; 2000 Sep; 37(9):653-7. PubMed ID: 10978354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis.
    Hosoya Y; Gemma A; Seike M; Kurimoto F; Uematsu K; Hibino S; Yoshimura A; Shibuya M; Kudoh S
    Lung Cancer; 1999 Aug; 25(2):87-93. PubMed ID: 10470842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutation of PTEN in bladder carcinoma.
    Aveyard JS; Skilleter A; Habuchi T; Knowles MA
    Br J Cancer; 1999 May; 80(5-6):904-8. PubMed ID: 10360673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity.
    Mavros A; Hahn M; Wieland I; Koy S; Koufaki ON; Strelocke K; Koch R; Haroske G; Schackert HK; Eckelt U
    J Oral Pathol Med; 2002 May; 31(5):270-6. PubMed ID: 12110043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic imbalance and mutations of the PTEN gene in ovarian cancer.
    Saito M; Okamoto A; Kohno T; Takakura S; Shinozaki H; Isonishi S; Yasuhara T; Yoshimura T; Ohtake Y; Ochiai K; Yokota J; Tanaka T
    Int J Cancer; 2000 Jan; 85(2):160-5. PubMed ID: 10629071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
    Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
    Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers.
    Zhou XP; Loukola A; Salovaara R; Nystrom-Lahti M; Peltomäki P; de la Chapelle A; Aaltonen LA; Eng C
    Am J Pathol; 2002 Aug; 161(2):439-47. PubMed ID: 12163369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
    Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
    Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
    Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
    Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.